The Center for Clinical Research (CCR) is an intergral part of the Bassett Research Institute. The CCR is located at the main Bassett campus in Cooperstown, New York.

The goal of the CCR is to conduct clinical research and clinical trials in various disciplines, with special interest in clinical outcomes, with the goal of developing and assessing treatments and treatment plans/protocols that improve the care and wellbeing of patients in our region

The CCR is designed to maximize investigator efficiency and support every step of the research process. The CCR provides support to investigators in the areas of:

Research question formulation
Protocol design
Preparation of IRB documents
Ongoing documentation with ClinicalTrials.gov
Recruiting and consenting study subjects
Documenting the study’s progress
Specimen collection, processing, storage, & shipping
Administration of study related questionnaires
Data collection & entry
Administration & management of study drug
Follow up visits with subjects
Performing initial screening to identify suitable subjects
Scheduling meetings with biostatisticians on sample size & optimal study design

Our Studies

Victorion2Prevent Study (V2P)

Getting To The Heart of Cardiovascular Disease. We’re testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease.

Influenza Virus

COMbination therapy with Baloxavir and Oseltamavir 1 for hospitalized patients with influenza—the Pragmatic COMBO1 trial.

VALOR

The VALOR investigational Lyme disease vaccine study is underway for healthy children and adults who live in or frequently visit areas that may expose them to ticks.

COMPLETE-2

COMPLETE – 2 is a randomized trial of physiology-guided versus angiography-guided nonculprit lesion (NCL) complete revascularization strategies and a large-scale observational study of Optical Coherence Tomography in patients with acute myocardial infarction and multivessel coronary artery disease.

This is a multicenter study sponsored by the Population Health Research Institute, Hamilton, Ontario, Canada.

Perosphere ClotChek studies™

Bassett Research Institute is participating in two clinical trials for a new Point of Care (POC) testing device used to measure clotting times for patients on different types of blood thinners. Patients taking Coumadin® (warfarin), Eliquis® (apixaban), or Xarelto® (rivaroxaban) may be eligible to participate.

Home Pulmonary Rehab for Pulmonary Embolism

The purpose of this pilot study is to learn whether a home rehabilitation program incorporating heart rate monitoring helps promote recovery and improves long term outcomes (reduce Post-PE Impairment). Being done in collaboration with the University of Rochester.